Related Experiment Video

Updated: Aug 25, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Atrial fibrillation in heart failure: prognostic significance and management

Gerald V Naccarelli1, B John Hynes, Deborah L Wolbrette

  • 1Division of Cardiology and the Penn State Cardiovascular Center, Penn State College of Medicine, Hershey, Pennsylvania 17033, USA. gnaccarelli@psu.edu

Journal of Cardiovascular Electrophysiology
|March 10, 2004
PubMed

Insights

Atrial fibrillation (AF) and heart failure often coexist. This review explores AF

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Atrial fibrillation (AF) and congestive heart failure (CHF) are prevalent cardiac conditions frequently occurring together.
  • The independent prognostic impact of AF in heart failure patients is not fully established and remains a subject of debate.
  • Managing these comorbid conditions requires careful consideration of treatment strategies.

Purpose of the Study:

  • To provide a comprehensive overview of atrial fibrillation in the context of heart failure.
  • To review the prevalence, prognostic implications, and therapeutic options for AF in heart failure patients.
  • To evaluate the efficacy of antiarrhythmic drugs in converting and maintaining sinus rhythm.

Main Methods:

  • Literature review of existing studies on atrial fibrillation and heart failure.
  • Analysis of the prognostic significance of AF as an independent risk factor.
  • Evaluation of antiarrhythmic drug efficacy and safety profiles.

Main Results:

  • Antiarrhythmic drugs with favorable hemodynamic profiles and neutral survival effects are preferred for AF management.
  • Standard heart failure therapies, including ACE inhibitors, ARBs, and beta-blockers, are integral to treatment.
  • Evidence on the prognostic significance of AF in heart failure is still debated.

Conclusions:

  • Optimal management of patients with concomitant AF and heart failure involves a multi-faceted approach.
  • Selection of antiarrhythmic agents should prioritize hemodynamic stability and survival.
  • Continued research is needed to clarify the prognostic role of AF in heart failure.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...